Consultant in biotech and bioindustrials to over 100 clients in top-tier management consulting firms, Fortune 500 companies, investment banks and hedge funds. Consulting core competencies include: market perspective, competitive landscape, startup company evaluation and technology analysis.
Expanded consulting work as a technology domain expert during period of multiple $100MM+ IPOs in biofuels, renewable chemicals and synthetic biology.
Company: Gerson Lehrman Group
Year(s): 2009 – Present
Results: Leading performer, invited to GLG Member Programs for extended client engagements